Pain Management Devices Market to Witness 21.5 % CAGR by 2031 | SkyQuest Technology [Yahoo! Finance]
Nevro Corp. (NVRO)
Last nevro corp. earnings: 2/25 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
nevro.com/english/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
2031, with a CAGR of 21.5% during the forecast period (2024-2031). The rise in chronic diseases is one of the major factors expected to drive the market expansion during the forecast period. Musculoskeletal stimulants are in high demand due to increasing incidence of lifestyle diseases such as diabetes and obesity. Another important factor that can drive the market expansion is the increasing incidence of stroke or hypertension. Cerebral atherosclerosis and other chronic diseases also contribute to a significant increase in blood pressure. The spread of the dangerous coronavirus has economic implications for almost every industry, including medical device manufacturers. The nationwide shutdown has affected patients who rely heavily on physiotherapy or exercise programs to manage pain. In addition, many elective surgeries and patient in-person visits were postponed or cancelled, which is expected to increase demand for home pain management. The number of cancer patients is expected to
Show less
Read more
Impact Snapshot
Event Time:
NVRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVRO alerts
High impacting Nevro Corp. news events
Weekly update
A roundup of the hottest topics
NVRO
News
- Nevro to Present at Wells Fargo 2024 Healthcare ConferencePR Newswire
- Nevro Corp. (NYSE: NVRO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08PR Newswire
- Engaged Capital Calls Nevro Corp. (NVRO) to Focus on Improving Profitability and Stop Pursuing Acquisitions [Yahoo! Finance]Yahoo! Finance
- Citi upgrades Nevro to neutral following sell-off [Seeking Alpha]Seeking Alpha
NVRO
Earnings
- 8/6/24 - Beat
NVRO
Sec Filings
- 9/10/24 - Form 4
- 9/10/24 - Form 4
- 9/10/24 - Form 4
- NVRO's page on the SEC website